<DOC>
	<DOCNO>NCT00571103</DOCNO>
	<brief_summary>The purpose study see whether acamprosate ( Campral ) curb desire gamble people pathological gamble disorder .</brief_summary>
	<brief_title>Acamprosate Treatment Pathological Gambling</brief_title>
	<detailed_description>Because opiate antagonist appear effective treatment pathological gambling ( PG ) , reasonable ask whether acamprosate ( calcium acetylhomotaurine ; Campral ) , also FDA approve treatment alcoholism , use effectively treat PG . Acamprosate opioid antagonist ; rather , assume therapeutic effect due action GABA receptor . Acamprosate structurally related 1-glutamic , excitatory neurotransmitter . It propose acamprosate decrease effect naturally-occuring excitatory neurotransmitter glutamate body . Because chronic alcohol consumption disrupts system , change last many month alcohol ingestion stop , possible acamprosate restores glutamate system towards normal . Regardless , acamprosate decrease pleasant `` high '' associate alcohol consumption , thus decrease frequency relapse abstinence . We hypothesize acamprosate similar action person PG .</detailed_description>
	<mesh_term>Gambling</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>Patients meet DSMIV criterion Pathological Gambling Disorder Patients achieve SOGS score great equal 5 Patients 18 year old old Patients speak standard English Patients able give write Informed Consent Patients able understand cooperate study procedures Patients current ( past 3 month ) substance use disorder ( except dependence ) Patients Hamilton Depression Rating score great equal 18 score # 1 ( depressed mood ) great 1 . Patients clinically significant medical illness Patients risk aggressive suicidal behavior Patients receive following intervention within proscribed time prior study entry : 1 ) monoamine oxidase inhibitor within previous 21 day ; 2 ) longacting phenothiazine within previous 3 month ; 3 ) psychotropic drug within previous 14 day ; 4 ) flu oxetine within previous 4 week . Patients severe antisocial borderline personality disorder Patients past current diagnosis schizophrenia , schizoaffective disorder , psychotic disorder , bipolar disorder , delirium , dementia , clinically significant cognitive disorder . Patients initiate individual , group , couple psychotherapy three moth prior study entry ( exclude Gambler 's Anonymous ) Patients prior exposure acamprosate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>